Sylvie Glaisner

1.5k total citations
17 papers, 330 citations indexed

About

Sylvie Glaisner is a scholar working on Genetics, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Sylvie Glaisner has authored 17 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Pathology and Forensic Medicine and 5 papers in Neurology. Recurrent topics in Sylvie Glaisner's work include Lymphoma Diagnosis and Treatment (6 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Glioma Diagnosis and Treatment (3 papers). Sylvie Glaisner is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), CNS Lymphoma Diagnosis and Treatment (4 papers) and Glioma Diagnosis and Treatment (3 papers). Sylvie Glaisner collaborates with scholars based in France, Australia and United States. Sylvie Glaisner's co-authors include Hervé Dombret, L Degos, Sylvie Castaigné, Franck Morschhauser, Richard Delarue, Corinne Haïoun, Jean Gabarre, Ju Li, Olivier Fitoussi and Bertrand Coiffier and has published in prestigious journals such as Blood, European Journal of Cancer and British Journal of Haematology.

In The Last Decade

Sylvie Glaisner

16 papers receiving 327 citations

Peers

Sylvie Glaisner
Gaetana Capobianco Italy
Lucille Baseggio France
Vít Campr Czechia
Marita Kloess Germany
Anna Ruskova New Zealand
Marjan Ertault France
Hanne Kuitunen Finland
NL Harris United States
F Parmentier France
Federica Quirini Italy
Gaetana Capobianco Italy
Sylvie Glaisner
Citations per year, relative to Sylvie Glaisner Sylvie Glaisner (= 1×) peers Gaetana Capobianco

Countries citing papers authored by Sylvie Glaisner

Since Specialization
Citations

This map shows the geographic impact of Sylvie Glaisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Glaisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Glaisner more than expected).

Fields of papers citing papers by Sylvie Glaisner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Glaisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Glaisner. The network helps show where Sylvie Glaisner may publish in the future.

Co-authorship network of co-authors of Sylvie Glaisner

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Glaisner. A scholar is included among the top collaborators of Sylvie Glaisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Glaisner. Sylvie Glaisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Glaisner, Sylvie, et al.. (2023). Posterior reversible encephalopathy syndrome (PRES) and myeloma. Leukemia Research Reports. 21. 100407–100407. 1 indexed citations
2.
Tavernier, Emmanuelle, Frédérique Kuhnowski, Jérôme Tamburini, et al.. (2020). Sinusoidal obstruction syndrome: a warning about autologous stem cell transplantation preceded by regimens containing oxaliplatin. Bone Marrow Transplantation. 55(9). 1834–1836. 3 indexed citations
3.
Tavernier, Emmanuelle, Frédérique Kuhnowski, Jérôme Tamburini, et al.. (2018). Sinusoidal Obstruction Syndrom (SOS): Warning about Autologous Stem Cell Transplantation (ASCT) Preceded By Regimens Containing Oxaliplatin. Blood. 132(Supplement 1). 4597–4597.
4.
Vargaftig, Jacques, H. Farhat, Lionel Adès, et al.. (2018). Phase 2 Trial of Single Agent Gedatolisib (PF-05212384), a Dual PI3K/mTOR Inhibitor, for Adverse Prognosis and Relapse/Refractory AML: Clinical and Transcriptomic Results. Blood. 132(Supplement 1). 5233–5233. 8 indexed citations
5.
Costopoulos, Myrto, Marie‐Laure Tanguy, Caroline Houillier, et al.. (2016). The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients. European Journal of Cancer. 61. 69–76. 68 indexed citations
6.
7.
Costopoulos, Myrto, Marie‐Laure Tanguy, Caroline Houillier, et al.. (2014). IL10 and IL10:IL6 Ratio in CSF Is Useful at Diagnosis but Also in the Assessment of Therapeutic Response in Patients with Primary Central Nervous System Lymphoma (PCNSL). Blood. 124(21). 1619–1619. 2 indexed citations
8.
9.
Rio, Monica Sierra del, Sylvain Choquet, Khê Hoang‐Xuan, et al.. (2011). Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma. Journal of Neuro-Oncology. 105(2). 409–414. 16 indexed citations
10.
Soussan, Michaël, et al.. (2008). Non-Hodgkin Lymphoma Localization in the Pituitary Gland. Clinical Nuclear Medicine. 33(2). 111–112. 16 indexed citations
11.
Lotz, Jean‐Pierre, Hervé Curé, Maud Janvier, et al.. (2004). High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol. European Journal of Cancer. 41(1). 71–80. 40 indexed citations
12.
Honderlick, P., et al.. (2000). [Microbiological diagnosis of bacteremia from a catheter: a simple method? Results of a retrospective study].. PubMed. 48(5). 467–9. 2 indexed citations
13.
Picard, C., et al.. (2000). Hydroxyurea-associated pneumonitis. 42(2-3). 158–159. 2 indexed citations
14.
Bastié, Jean, Dominique Cazals‐Hatem, MT Daniel, et al.. (1999). Five Years Follow-Up after 2-Chloro Deoxyadenosine Treatment in Thirty Patients with Hairy Cell Leukemia: Evaluation of Minimal Residual Disease and CD4+ Lymphocytopenia after Treatment. Leukemia & lymphoma. 35(5-6). 555–565. 39 indexed citations
15.
Honderlick, P., et al.. (1999). Diagnostic microbiologique de bactériémie liée à une chambre implantable: une méthode simple? Résultats d’une étude rétrospective. La Revue de Médecine Interne. 20. 557s–557s. 1 indexed citations
16.
Jourdan, Éric, et al.. (1995). Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic component. British Journal of Haematology. 89(3). 527–530. 32 indexed citations
17.
Dombret, Hervé, Sarah S. Geiger, Sylvie Glaisner, et al.. (1995). Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?. PubMed. 9(9). 1473–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaetana Capobianco Breakdown of academic impact, for papers by Lucille Baseggio Breakdown of academic impact, for papers by Vít Campr Breakdown of academic impact, for papers by Marita Kloess Breakdown of academic impact, for papers by Anna Ruskova Breakdown of academic impact, for papers by Marjan Ertault Breakdown of academic impact, for papers by Hanne Kuitunen Breakdown of academic impact, for papers by NL Harris Breakdown of academic impact, for papers by F Parmentier Breakdown of academic impact, for papers by Federica Quirini
Rankless by CCL
2026